As of 2025-09-18, the Intrinsic Value of 89Bio Inc (ETNB) is -15.18 USD. This 89Bio valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.08 USD, the upside of 89Bio Inc is -287.84%.
Based on its market price of 8.08 USD and our intrinsic valuation, 89Bio Inc (ETNB) is overvalued by 287.84%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -15.18 - -15.18 | -15.18 | -287.84% |
| P/E | (20.76) - (35.03) | (26.49) | -427.8% |
| DDM - Stable | (23.60) - (81.50) | (52.55) | -750.4% |
| DDM - Multi | (0.39) - (1.01) | (0.56) | -106.9% |
| Market Cap (mil) | 1,198.34 |
| Beta | 1.49 |
| Outstanding shares (mil) | 148.31 |
| Enterprise Value (mil) | 1,105.42 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.18% |
| Cost of Debt | 5.00% |
| WACC | 10.03% |